In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial

Antibiotic sensitivity testing. Report of an international collaborative study.

1971 • 1,185 citations

Quinolone Antimicrobial Agents

1992 • 209 citations

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1993 • 134 citations

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1993 • 125 citations

Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents

1989 • 94 citations

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus:clinical significance and therapeutic approaches

1990 • 83 citations

Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus.

1988 • 69 citations

Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa

1986 • 69 citations

CIPROFLOXACIN RESISTANCE IN EPIDEMIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

1988 • 41 citations

New quinolones in development

1994 • 40 citations

In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents

1989 • 31 citations

Sparfloxacin and other new fluoroquinolones

1992 • 19 citations